Advertisement
Skip to Content

Abbott Laboratories ABT Stock Quote

| Rating as of

NYSE: ABT

Last close prices updated as of Jan 27, 2023, 7:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 109.95
  • Sector Healthcare
  • Industry Medical Devices
  • Investment Style Large Blend
  • Day Range 109.81  –  111.26
  • Year Range 93.25  –  130.94
  • Market Cap 191.7059 Bil
  • Volume / Avg 4.9 Mil /  4.9 Mil
  • Price / Sales 4.44
  • Price / Book 5.37
  • Forward Div Yield 1.82%
  • Trailing Div Yield 1.75%

Morningstar‘s Stock Analysis ABT

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Abbott’s New Devices Soften Turbulence From Diagnostics and Pediatric Nutrition; No Change to FVE

Debbie S. Wang Senior Equity Analyst

Analyst Note

| Debbie Wang |

Narrow-moat Abbott reported full-year results that modestly outpaced our expectations on the top line, but this was offset by slightly lower profitability than we’d estimated. This was a wash on our valuation and we’re leaving our fair value estimate unchanged. Based on fourth-quarter performance, Abbott remains in the midst of steering through the decline in demand for pandemic-related diagnostics and the early stages of recovering from the U.S. infant formula recall. Fortunately, the firm is well-armed with a range of new devices that should provide some ballast.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics ABT

Company Profile ABT

Business Description

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Contact
100 Abbott Park Road
Abbott Park, IL, 60064-6400
Industry Medical Devices
Employees 113,000

Related Articles ABT

FAQs for Abbott Laboratories Stock

Yes. ABT has a forward dividend yield of 1.82%. See ABT’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

ABT’s market cap is 191.71 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

ABT’s stock style is Large Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

ABT’s price/sales is 4.44.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

ABT’s price/forward earnings is 25.19.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

ABT’s price/book is 5.37.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See ABT’s valuation ratios compared to the Market Index.

ABT’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare ABT’s historical performance against its industry peers and the overall market.